Skip to main content

Advertisement

Log in

Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Recurrent dislocation of the mandibular condyle poses a difficult problem for affected patients. In the course of time, dislocations often become more frequent and more difficult to avoid. Even with good patient compliance, conservative treatment is often not sufficient. Operative procedures have also been described for the treatment of temporomandibular joint dislocation. However, these interventions are invasive, involving open arthrotomy with possible complications, and cannot safely guarantee a successful outcome. On the other hand, botulinum toxin injections into the lateral pterygoid muscles offer the option of a predictable and prolonged period without renewed dislocation. We present the results of this treatment carried out in 21 patients with recurrent temporomandibular joint dislocation. Four patients were treated following unsuccessful physical therapy and the use of occlusal splints. The remaining 17 patients were treated for a number of conditions resulting in dislocation, including some with senile dementia and mental impairment in whom compliance with conservative measures was poor or completely absent. Injections were given on a 3-month basis in order to have a sustained effect. Within the study period of 6 months to 3 years, only two of the 21 patients suffered further dislocation. There were no side effects recorded as a result of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Borodic G, Johnson E, Goodnough M, Schantz E (1996) Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology 46: 26–29

    CAS  PubMed  Google Scholar 

  2. Borodic GE, Acquardo MA (2002) The use of botulinum toxin for the treatment of chronic facial pain. J Pain 3: 21–27

    Article  Google Scholar 

  3. Daelen B, Thorwirth V, Koch A (1997) Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin. Int J Oral Maxillofac Surg 26: 458–460

    CAS  PubMed  Google Scholar 

  4. Daelen B, Koch A, Thorwirth V (1998) Botulinumtoxinbehandlung der neurogenen Kiefergelenkluxation. Mund Kiefer GesichtsChir 2: 125–129

    Google Scholar 

  5. Freund B, Schwartz M, Symington IM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57: 916–921

    CAS  PubMed  Google Scholar 

  6. Freund B, Schwartz M, Symington JM (2000) Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 38: 466–471

    Article  CAS  PubMed  Google Scholar 

  7. Holmlund AB, Gynther GW, Kardel R, Axelsson SE (1999) Surgical treatment of temporomandibular joint luxation. Swed Dent J 23: 127–132

    CAS  PubMed  Google Scholar 

  8. Moore AP, Wood GD (1997) Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J 183: 415–417

    CAS  PubMed  Google Scholar 

  9. Naumann M, Hefter H, Heinen F (1999) Dysport. Klinische Anwendung von Botulinumtoxin. Uni-Med, Bremen

  10. Porta M (2000) A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85: 101–105

    Article  CAS  PubMed  Google Scholar 

  11. Roser M, Cornelius CP, Topka H (1988) Neuerungen in der MKG-Chirurgie. Lokale Injektionsbehandlung mit Botulinumtoxin A. Mund Kiefer Gesichtschir 2: 121–124

    Google Scholar 

  12. Umstadt HE (2002) Botulinum toxin in craniomaxillofacial surgery. Mund Kiefer GesichtsChir 6: 236–240

    PubMed  Google Scholar 

  13. Von Lindern JJ, Niederhagen B, Bergé S, Appel T, Reich RH (2000) Die Behandlung der muskulären Hyperaktivität der Kaumuskulatur mit Botulinumtoxin Typ A. Dtsch Zahnärztl Z 55: 26–29

    Google Scholar 

  14. Von Lindern JJ (2001) Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction. Acta Neurol Belg 101: 39–41

    PubMed  Google Scholar 

  15. Zuber M, Sebald M, Bathien N, de Recondo J, Rondot P (1993) Botulinum antibodies in dystonic patients treated with type A botulinum toxin. Frequency and significance. Neurology 43: 1715–1718

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph M. Ziegler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziegler, C.M., Haag, C. & Mühling, J. Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection. Clin Oral Invest 7, 52–55 (2003). https://doi.org/10.1007/s00784-002-0187-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-002-0187-y

Keywords

Navigation